Research location
Sheffield
South Yorkshire, United Kingdom
Advertisement
Research activity in Sheffield
South Yorkshire, United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 89 trials and 94 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Sheffield
89 linked trials · page 1 of 2The Use of Advanced Imaging in HFpEFNCT06905405 · 2025-08-05 · 1 site observation
RECRUITING
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.NCT06846281 · 2025-06-23 · 1 site observation
RECRUITING
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)NCT06966401 · 2025-04-16 · 1 site observation
RECRUITING
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)NCT06649110 · 2024-10-24 · 1 site observation
RECRUITING
Developing the Probability Algorithm for Pulmonary Hypertension EchocardiographyNCT06386185 · 2024-09-06 · 1 site observation
RECRUITING
RCT of Implantable Defibrillators in Patients With Non Ischemic Cardiomyopathy, Scar and Severe Systolic Heart FailureNCT05568069 · 2023-04-12 · 1 site observation
RECRUITING
Feasibility of Novel Clinical Trial Infrastructure, Design and Technology for Early Phase Studies in Patients With Pulmonary Hypertension (FIT-PH)NCT04078243 · 2020-01-21 · 1 site observation
RECRUITING
A Pilot Study of the VosCryoTM Breathalyser in Lung CancerNCT07689968 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
Self-Help Booklets for Sleep in Adults With Pulmonary HypertensionNCT07754981 · 2026-09-01 · 1 site observation
NOT_YET_RECRUITING
Exercise to Boost Immunity in Advanced CancerNCT06310993 · 2025-09-01 · 1 site observation
NOT_YET_RECRUITING
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic SclerosisNCT06655896 · 2024-10-29 · 1 site observation
ACTIVE_NOT_RECRUITING
Improving Pulmonary Hypertension Screening by EchocardiographyNCT06038149 · 2023-11-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Probiotic Intervention for People With Multiple SclerosisNCT07304713 · 2023-06-20 · 1 site observation
COMPLETED
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)NCT05649722 · 2023-05-11 · 1 site observation
COMPLETED
Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension ParticipantsNCT05764265 · 2023-03-27 · 1 site observation
TERMINATED
A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of AgeNCT05399888 · 2022-08-24 · 1 site observation
ACTIVE_NOT_RECRUITING
DEXCOM ONE: Continuous Glucose Monitoring in the Real World, Utility of Sustained High AlertsNCT05453344 · 2022-08-10 · 1 site observation
COMPLETED
Study of Efficacy and Safety of LTP001 in Pulmonary Arterial HypertensionNCT05135000 · 2022-06-30 · 1 site observation
TERMINATED
Acceptability of Exoskeleton Assisted Walking for Persons With Mobility Issues Due to Multiple SclerosisNCT04786821 · 2022-06-23 · 1 site observation
COMPLETED
Muscle in Obesity: Imaging, Function and microRNANCT04300504 · 2021-09-01 · 1 site observation
COMPLETED
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCNCT04821622 · 2021-05-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Optimising Secondary Prevention and Quality of Life in Early Cardiac RehabilitationNCT04781699 · 2021-03-19 · 1 site observation
UNKNOWN
Atrasentan in Patients With Proteinuric Glomerular DiseasesNCT04573920 · 2021-03-15 · 1 site observation
ACTIVE_NOT_RECRUITING
Assessing the Repeatability of NT-proBNP Testing Using Laboratory and Point of Care Testing in PAHNCT05421949 · 2021-02-19 · 1 site observation
COMPLETED
Anxiety Self-management Intervention for Pulmonary HypertensionNCT04450862 · 2020-08-05 · 1 site observation
UNKNOWN
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung PhysiologyNCT04872309 · 2019-09-04 · 1 site observation
SUSPENDED
RIPC on Activity, Fatigue and Gait in MSNCT03967106 · 2019-08-19 · 1 site observation
COMPLETED
Probiotic Use in Parkinson's DiseaseNCT04140760 · 2019-08-14 · 1 site observation
UNKNOWN
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's DiseaseNCT03887455 · 2019-03-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MSNCT03650114 · 2018-12-28 · 1 site observation
ACTIVE_NOT_RECRUITING
Trial of Ursodeoxycholic Acid (UDCA) for Parkinson's Disease: The "UP" StudyNCT03840005 · 2018-12-18 · 1 site observation
COMPLETED
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB078 in Adults With C9ORF72-Associated Amyotrophic Lateral SclerosisNCT03626012 · 2018-09-10 · 1 site observation
COMPLETED
Efficacy and Safety Study of BIIB074 in Participants With Small Fiber NeuropathyNCT03339336 · 2018-05-31 · 1 site observation
TERMINATED
Feasibility and Acceptability of Orthotic Shorts for People With Multiple SclerosisNCT03164031 · 2018-01-10 · 1 site observation
COMPLETED
Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced MalignanciesNCT03317496 · 2017-12-21 · 1 site observation
TERMINATED
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up StudiesNCT03269175 · 2017-09-29 · 1 site observation
COMPLETED
Phase Ib/II Study of M3814 With Etoposide and Cisplatin in Small Cell Lung Cancer (SCLC) Extensive Disease (ED)NCT03116971 · 2017-05-25 · 1 site observation
TERMINATED
Ischemic Preconditioning, Exercise Tolerance and Multiple SclerosisNCT03153553 · 2017-04-05 · 1 site observation
COMPLETED
A COMbined progRamme of Exercise and Dietary ADvice in mEn With Castrate Resistant Prostate CancerNCT03017417 · 2017-02-08 · 1 site observation
COMPLETED
A 24-Month Study to Evaluate the Efficacy and Safety of Elenbecestat (E2609) in Participants With Early Alzheimer's DiseaseNCT02956486 · 2016-10-20 · 1 site observation
TERMINATED
Assessment of Bone Loss in Men Receiving Treatment for Prostate CancerNCT02785627 · 2016-09-01 · 1 site observation
UNKNOWN
Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.NCT02792231 · 2016-08-26 · 1 site observation
COMPLETED
QVA Mechanistic Efficacy Study (Receptor Effects, Etc)NCT02634983 · 2016-06-03 · 1 site observation
COMPLETED
High Intensity Interval Training for People With Mild Multiple Sclerosis: A Feasibility StudyNCT02702804 · 2016-04-21 · 1 site observation
COMPLETED
Quantitative Assessment and Characterization of Microvascular Function Using Diffuse Optical TomographyNCT03411213 · 2016-01-11 · 1 site observation
COMPLETED
Efficacy and Safety Study of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.NCT02555683 · 2015-12-11 · 1 site observation
COMPLETED
A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination CoursesNCT02434848 · 2015-07-23 · 1 site observation
COMPLETED
A Comparison of European and Chinese Blood Sugar ResponsesNCT02577874 · 2015-06-01 · 1 site observation
UNKNOWN
Exercise Training as a Novel Primary Therapy for Men With Localised Prostate CancerNCT02409212 · 2015-05-01 · 1 site observation
COMPLETED
Chronic Thrombo-embolic Pulmonary Hypertension: Classification and Long Term OutcomeNCT02565030 · 2015-02-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.